I-123 MIBG Scintigraphy in Idiopathic Dilated Cardiomyopathy: Where Next?

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2002 Feb 15

PMID 11845138

Authors

Kevin C Allman

Avijit Lahiri

Affiliations

Soon will be listed here.

References

Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande J, DUVAL A . Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med. 1999; 40(6):917-23. View

Wieland D, Brown L, Rogers W, Worthington K, Wu J, Clinthorne N . Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med. 1981; 22(1):22-31. View

Yamazaki J, Muto H, Kabano T, Yamashina S, Nanjo S, Inoue A . Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography. Am Heart J. 2001; 141(4):645-52. DOI: 10.1067/mhj.2001.112783. View

Zhao C, Shuke N, Yamamoto W, Okizaki A, Sato J, Ishikawa Y . Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT. J Nucl Med. 2001; 42(7):1017-24. View

Murata K, Kusachi S, Murakami T, Nogami K, Murakami M, Hirohata S . Relation of iodine-123 metaiodobenzylguanidine myocardial scintigraphy to endomyocardial biopsy findings in patients with dilated cardiomyopathy. Clin Cardiol. 1997; 20(1):61-6. PMC: 6656273. DOI: 10.1002/clc.4960200113. View

Beanlands R, Schwaiger M . Changes in myocardial oxygen consumption and efficiency with heart failure therapy measured by 11C acetate PET. Can J Cardiol. 1995; 11(4):293-300. View

Calkins H, Allman K, Bolling S, Kirsch M, Wieland D, Morady F . Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart. Circulation. 1993; 88(1):172-9. DOI: 10.1161/01.cir.88.1.172. View

Parthenakis F, Prassopoulos V, Koukouraki S, Zacharis E, Diakakis G, Karkavitsas N . Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: relationship to regional wall motion and myocardial perfusion abnormalities. J Nucl Cardiol. 2002; 9(1):15-22. DOI: 10.1067/mnc.2002.118239. View

Somsen G, Van Vlies B, de Milliano P, Borm J, van Royen E, Endert E . Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure. Heart. 1996; 76(3):218-22. PMC: 484510. DOI: 10.1136/hrt.76.3.218. View

10.

Di Carli M, Tobes M, Mangner T, Levine A, Muzik O, Chakroborty P . Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med. 1997; 336(17):1208-15. DOI: 10.1056/NEJM199704243361703. View

11.

Nakata T, Miyamoto K, Doi A, Sasao H, Wakabayashi T, Kobayashi H . Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol. 1998; 5(6):579-90. DOI: 10.1016/s1071-3581(98)90112-x. View

12.

Suwa M, Otake Y, Moriguchi A, Ito T, Hirota Y, Kawamura K . Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy. Am Heart J. 1997; 133(3):353-8. DOI: 10.1016/s0002-8703(97)70232-1. View

13.

Somsen G, Borm J, de Milliano P, Van Vlies B, Dubois E, van Royen E . Quantitation of myocardial iodine-123 MIBG uptake in SPET studies: a new approach using the left ventricular cavity and a blood sample as a reference. Eur J Nucl Med. 1995; 22(10):1149-54. DOI: 10.1007/BF00800597. View

14.

Momose M, Kobayashi H, Iguchi N, Matsuda N, Sakomura Y, Kasanuki H . Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy. Nucl Med Commun. 1999; 20(6):529-35. DOI: 10.1097/00006231-199906000-00007. View

15.

Tseng H, Link J, Stratton J, Caldwell J . Cardiac receptor physiology and its application to clinical imaging: present and future. J Nucl Cardiol. 2001; 8(3):390-409. DOI: 10.1067/mnc.2001.115645. View

16.

Imamura Y, Fukuyama T, Mochizuki T, Miyagawa M, Watanabe K . Prognostic value of iodine-123-metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy. Jpn Circ J. 2001; 65(3):155-60. DOI: 10.1253/jcj.65.155. View

17.

Imamura Y, Ando H, Mitsuoka W, Egashira S, Masaki H, Ashihara T . Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol. 1995; 26(7):1594-9. DOI: 10.1016/0735-1097(95)00374-6. View

18.

Naruse H, Arii T, Kondo T, Ohnishi M, Sakaki T, Takahashi K . Relation between myocardial response to dobutamine stress and sympathetic nerve activation in patients with idiopathic dilated cardiomyopathy: a comparison of 123I-MIBG scintigraphic and echocardiographic data. Ann Nucl Med. 2001; 14(6):427-32. DOI: 10.1007/BF02988288. View

19.

Vigna C, Fusilli S, Natali R, Russo A, De Rito V, Siena G . Neuroadrenergic activation and response to dobutamine in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol. 2000; 86(4):422-6. DOI: 10.1016/s0002-9149(00)00958-9. View

20.

Paraskevaidis I, Adamopoulos S, Kremastinos D . Dobutamine echocardiographic study in patients with nonischemic dilated cardiomyopathy and prognostically borderline values of peak exercise oxygen consumption: 18-month follow-up study. J Am Coll Cardiol. 2001; 37(6):1685-91. DOI: 10.1016/s0735-1097(01)01194-9. View